Shock

Shock – High‑Yield Study Guide for Medical Students

Definition

Shock is an acute, life‑threatening circulatory failure resulting in inadequate tissue perfusion and oxygen delivery to meet metabolic demands, leading to cellular dysfunction, organ failure, and, if uncorrected, death.

It is a clinical syndrome, not a single disease, and is characterized by systemic hemodynamic derangements and evidence of end‑organ hypoperfusion (e.g. altered mental status, oliguria, lactic acidosis).

Epidemiology

Shock is common in emergency and intensive care settings and is a major cause of morbidity and mortality.

• Septic shock is the most frequent type of shock in the ICU and has the highest mortality, often 30–50% despite modern care.[4]
• Cardiogenic shock most often complicates acute myocardial infarction and is a leading cause of in‑hospital death after STEMI.
• Hypovolemic shock is common in trauma, gastrointestinal bleeding, and obstetric hemorrhage.
• Distributive shock (especially septic shock) is increasingly recognized in older adults, patients with diabetes, and the immunocompromised.[4]

Classification and Types of Shock

Shock is traditionally classified into four major types, often with overlapping features (“mixed shock”):

• Hypovolemic shock – due to reduced intravascular volume (e.g. hemorrhage, fluid loss).
• Cardiogenic shock – due to primary pump failure (e.g. MI, severe cardiomyopathy, arrhythmias).
• Obstructive shock – due to mechanical obstruction of cardiac filling or outflow (e.g. tension pneumothorax, cardiac tamponade, massive PE).
• Distributive shock – due to severe peripheral vasodilation and maldistribution of blood flow; most commonly septic shock, but also anaphylactic and neurogenic shock.

Pathophysiology

Global Principles

The central problem in shock is mismatch between oxygen delivery (DO₂) and oxygen consumption (VO₂).

• Oxygen delivery depends on cardiac output (CO = HR × stroke volume) and arterial oxygen content (related to hemoglobin and SaO₂).
• When DO₂ falls, tissues increase oxygen extraction until a critical point; beyond this, anaerobic metabolism ensues, leading to lactic acidosis.
• Prolonged shock leads to cellular injury, mitochondrial dysfunction, capillary leak, and multi‑organ failure (MOF).

Pathophysiology by Type

• Hypovolemic shock
  • Loss of circulating volume (blood or plasma) → ↓ venous return (preload) → ↓ stroke volume and cardiac output.
  • Compensatory mechanisms: tachycardia, peripheral vasoconstriction, activation of RAAS and sympathetic nervous system.
• Cardiogenic shock
  • Primary pump failure (e.g. LV dysfunction after MI) → ↓ stroke volume despite adequate or increased preload.
  • ↑ LV end‑diastolic pressure and pulmonary congestion; systemic vasoconstriction increases afterload and worsens cardiac output.
• Obstructive shock
  • Mechanical factors impede cardiac filling or ejection: tamponade (↑ pericardial pressure), tension pneumothorax (↑ intrathoracic pressure), massive PE (↑ pulmonary vascular resistance).
  • Result: functionally similar to cardiogenic shock with low forward flow despite normal myocardium.
• Distributive shock (especially septic)
  • Systemic inflammatory response leads to profound vasodilation, ↓ systemic vascular resistance (SVR), and relative hypovolemia due to capillary leak.
  • Early septic shock: often high or normal cardiac output with low SVR (“warm shock”), progressing to low cardiac output in late stages.
  • Inflammatory mediators and endotoxins directly impair mitochondrial function and microcirculatory regulation, causing tissue hypoxia despite apparently adequate macrocirculatory flow.[4]

Stages of Shock

• Initial stage – subclinical; decreased DO₂ and onset of anaerobic metabolism; lactate begins to rise.
• Compensated (non‑progressive) stage – neurohumoral responses maintain blood pressure: tachycardia, peripheral vasoconstriction, oliguria; mental status may still be preserved.
• Progressive stage – worsening tissue hypoperfusion, metabolic acidosis, endothelial injury, and microthrombi; clinical hypotension and organ dysfunction.
• Refractory (irreversible) stage – severe, irreversible cellular and organ damage; resuscitation fails to restore function.

Clinical Presentation

General Signs of Shock

Regardless of etiology, shock presents with signs of systemic hypoperfusion and sympathoadrenal activation.

• Vital signs
  • Tachycardia (often earliest sign, except in beta‑blocked or very young/elderly).
  • Hypotension: systolic < 90 mmHg or MAP < 65 mmHg, or >40 mmHg drop from baseline.
  • Tachypnea and possible respiratory distress.
  • Narrow pulse pressure in hypovolemic/cardiogenic shock; wide pulse pressure in early distributive shock.
• End‑organ hypoperfusion
  • Altered mental status: agitation, anxiety, confusion, lethargy.
  • Oliguria (<0.5 mL/kg/h) or anuria.
  • Cold, clammy skin with delayed capillary refill >2–3 seconds in hypovolemic/cardiogenic/obstructive shock.
  • Metabolic (lactic) acidosis on labs.

Type‑Specific Clinical Features

• Hypovolemic shock
  • History of fluid loss: trauma, GI bleed (melena, hematemesis), vomiting, diarrhea, burns.
  • Physical exam: dry mucous membranes, decreased skin turgor (non‑hemorrhagic), flat neck veins, cool extremities.
• Cardiogenic shock
  • History: chest pain, known CAD or heart failure, recent MI, cardiomyopathy, valvular disease.
  • Physical exam: signs of congestion (elevated JVP, pulmonary crackles, S3 gallop, peripheral edema), cool clammy skin.
• Obstructive shock
  • Tension pneumothorax: sudden dyspnea, hypotension, unilateral absent breath sounds, tracheal deviation, hyperresonance, distended neck veins.
  • Cardiac tamponade: Beck triad (hypotension, muffled heart sounds, elevated JVP), tachycardia, pulsus paradoxus.
  • Massive PE: acute dyspnea, pleuritic chest pain, syncope, hypotension, tachycardia, signs of right heart strain.
• Distributive shock
  • Septic shock: suspected or confirmed infection, fever or hypothermia, warm flushed skin early (“warm shock”), bounding pulses, wide pulse pressure; later may become cold as CO falls.[4]
  • Anaphylactic shock: rapid onset after allergen exposure; urticaria, angioedema, wheezing, stridor, hypotension, GI symptoms.
  • Neurogenic shock: cervical or high thoracic spinal cord injury; hypotension with bradycardia and warm dry skin due to loss of sympathetic tone.

Diagnosis

Initial Assessment

Diagnosis is primarily clinical and must be made rapidly.

• ABC assessment: airway, breathing, circulation; look for immediate life‑threatening causes (e.g. tension pneumothorax, massive hemorrhage).
• Hemodynamic evaluation: blood pressure, heart rate, capillary refill, extremity temperature, mental status, urine output.
• History and focused exam to identify likely etiology (trauma, infection, chest pain, allergic trigger, neurologic injury).

Baseline Investigations

• Laboratory tests
  • ABG and lactate (marker of tissue hypoperfusion; trending useful for resuscitation endpoints).
  • CBC, electrolytes, renal and liver function, coagulation profile.
  • Blood glucose.
  • Cardiac biomarkers (troponin, BNP) in suspected cardiogenic shock.
  • Cultures (blood, urine, sputum, etc.) if septic shock suspected.[4]
• Imaging
  • Chest X‑ray: pneumonia, pulmonary edema, widened mediastinum, pneumothorax.
  • Point‑of‑care ultrasound (POCUS): evaluates IVC, LV/RV function, pericardial effusion, pneumothorax, free fluid in abdomen.
  • CT scans (e.g. CT pulmonary angiography, CT abdomen/pelvis) as clinically appropriate.
• Hemodynamic monitoring
  • Continuous ECG, noninvasive BP, pulse oximetry.
  • Arterial line for beat‑to‑beat BP and blood gases/lactate in unstable patients.
  • Central venous catheter for vasopressors and CVP/lab sampling in selected patients.

Etiology‑Specific Diagnostic Clues

• Hypovolemic shock: history of loss; low JVP; small IVC on ultrasound; low hemoglobin if hemorrhagic; high BUN:Cr in GI loss.
• Cardiogenic shock: ECG changes of ischemia; elevated troponin; echo showing reduced LV function, regional wall motion abnormalities.
• Obstructive shock: echo showing pericardial effusion or RV dilation; ultrasound or CXR for tension pneumothorax; CT/echo for massive PE.
• Septic shock: evidence of infection, elevated inflammatory markers, positive cultures, and septic shock criteria (hypotension requiring vasopressors to maintain MAP ≥65 mmHg plus lactate >2 mmol/L despite adequate fluid resuscitation).[4]

Management

General Principles

Management prioritizes rapid recognition, immediate stabilization, and definitive treatment of the underlying cause.

• 1. Airway and breathing
  • Supplemental oxygen to maintain SpO₂ ≥ 94% (or individualized targets in COPD).
  • Early intubation and mechanical ventilation if there is airway compromise, respiratory failure, or severe shock; this reduces work of breathing and oxygen consumption.
• 2. Circulation and hemodynamic support
  • Establish 2 large‑bore IV lines or central access.
  • Fluid resuscitation is usually first‑line in hypovolemic and distributive shock: isotonic crystalloids (e.g. 30 mL/kg bolus in septic shock, then reassess using dynamic measures).[4]
  • Use vasopressors early if hypotension persists despite fluids or if fluid overload is a concern (e.g. cardiogenic shock).
• 3. Treat the underlying cause
  • Stop bleeding, treat infection, relieve obstruction, or correct pump failure (see type‑specific management below).

Type‑Specific Management

Hypovolemic Shock

• Hemorrhagic
  • Immediate control of bleeding (direct pressure, tourniquet, surgery, endoscopy, interventional radiology).
  • Massive transfusion protocol when indicated (balanced resuscitation with packed RBCs, plasma, platelets).
  • Permissive hypotension in some trauma patients until hemorrhage control (avoid in TBI).
• Non‑hemorrhagic (e.g. dehydration, third spacing)
  • Aggressive isotonic crystalloid resuscitation.
  • Treat underlying cause: antiemetics, antidiarrheals, manage pancreatitis, burns, etc.

Cardiogenic Shock

• Identify and treat precipitating cause: acute MI (revascularization with PCI/CABG), severe valvular disease, arrhythmias.
• Use cautious fluid administration; avoid large boluses if pulmonary edema present.
• Vasopressors (e.g. norepinephrine) to maintain MAP.
• Inotropes (e.g. dobutamine) to improve cardiac contractility.
• Mechanical circulatory support in refractory cases: intra‑aortic balloon pump, Impella, VA‑ECMO.

Obstructive Shock

• Tension pneumothorax: immediate needle decompression followed by chest tube.
• Cardiac tamponade: urgent pericardiocentesis or surgical drainage.
• Massive pulmonary embolism: systemic thrombolysis, catheter‑directed therapy, or surgical embolectomy depending on context.

Distributive Shock

Septic Shock

• Early recognition and management according to sepsis guidelines.
• Fluids: initial 30 mL/kg isotonic crystalloids within first 3 hours, reassessing continuously.[4]
• Antibiotics: broad‑spectrum IV antibiotics within 1 hour of recognition, then narrow based on cultures.[4]
• Source control: drainage of abscess, removal of infected devices, debridement of necrotic tissue.
• Vasopressors: norepinephrine is first‑line to maintain MAP ≥ 65 mmHg; add vasopressin or epinephrine if needed.
• Adjuncts: consider low‑dose corticosteroids in refractory septic shock.

Anaphylactic Shock

• Immediate intramuscular epinephrine in the mid‑anterolateral thigh is first‑line.
• Airway management, high‑flow oxygen, and aggressive fluid resuscitation.
• Adjunctive therapies: antihistamines, corticosteroids, bronchodilators.

Neurogenic Shock

• Spinal immobilization and definitive management of spinal cord injury.
• Judicious fluid resuscitation; vasopressors (e.g. norepinephrine) to counteract vasodilation.
• Atropine or pacing may be needed for severe bradycardia.

Monitoring Response to Therapy

• Clinical improvement: normalization of mental status, urine output ≥ 0.5 mL/kg/h, warm extremities, improved capillary refill.
• Hemodynamic targets: MAP ≥ 65 mmHg, improving heart rate and blood pressure.
• Laboratory markers: decreasing lactate levels, improving acid–base status.

Complications and Prognosis

• Acute kidney injury, acute respiratory distress syndrome (ARDS), acute liver injury.
• Cardiac ischemia, arrhythmias, and heart failure.
• Disseminated intravascular coagulation (DIC) in severe sepsis/trauma.
• Long‑term cognitive impairment and functional decline in ICU survivors.
• Prognosis depends on etiology, speed of recognition, and adequacy of resuscitation; septic and cardiogenic shock carry the highest mortality.[4]

Key Clinical Pearls for Exams and Practice

• Shock is a clinical diagnosis – do not wait for hypotension; early signs include tachycardia, cool extremities, and altered mentation.
• Think type of shock from the physical exam:
  • Cold, clammy, low JVP → hypovolemic.
  • Cold, clammy, high JVP, pulmonary edema → cardiogenic or obstructive.
  • Warm, flushed skin, wide pulse pressure → early distributive (e.g. septic, anaphylactic).
• Always search for and treat reversible causes (e.g. tension pneumothorax, tamponade, massive hemorrhage) during initial assessment.
• Lactate and urine output are key markers of tissue perfusion and resuscitation adequacy.
• Septic shock requires three early priorities: fluids, broad‑spectrum antibiotics, and source control plus vasopressors as needed.[4]
• Cardiogenic shock is fluid‑intolerant; prioritize inotropes, vasopressors, and early revascularization in MI.
• Obstructive shock improves only when the obstruction is relieved; supportive care alone is insufficient.
• Consider patient factors (age, comorbidities like diabetes and cardiovascular disease) that increase the risk and worsen outcomes in shock states.[4][3]

Summary

Shock is an emergency characterized by circulatory failure and inadequate tissue perfusion. Understanding the types of shock, their distinct pathophysiologic mechanisms, and typical clinical patterns allows rapid diagnosis and targeted therapy. Early recognition, prompt resuscitation, and definitive treatment of the underlying cause are crucial to reduce organ failure and mortality.[4]